JP Morgan Chase’s Neuraxis NRXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11
Closed -$34 7660
2025
Q3
$34 Buy
11
+2
+22% +$5 ﹤0.01% 7252
2025
Q2
$22 Buy
9
+2
+29% +$5 ﹤0.01% 6952
2025
Q1
$15 Sell
7
-1
-13% -$2 ﹤0.01% 7162
2024
Q4
$19 Hold
8
﹤0.01% 7274
2024
Q3
$24 Hold
8
﹤0.01% 7235
2024
Q2
$22 Buy
8
+2
+33% +$6 ﹤0.01% 7158
2024
Q1
$19 Buy
6
+4
+200% +$12 ﹤0.01% 7173
2023
Q4
$5 Buy
+2
New +$5 ﹤0.01% 7451

Other funds holding NRXS

JP Morgan Chase's NRXS Position: Q4 2025 in Review

JP Morgan Chase sold out of Neuraxis (NRXS) in Q4 2025, closing a stake of 11 shares — an estimated $34 sold.

JP Morgan Chase first reported a position in NRXS in Q4 2023 and held it in 8 quarters. The position peaked at $34 in Q3 2025. 18 funds tracked by Wall St. Rank hold NRXS as of Q4 2025.

  • JP Morgan Chase reported no remaining Neuraxis position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 11 Neuraxis shares in Q4 2025, an estimated $34.
  • JP Morgan Chase first reported a position in Neuraxis in Q4 2023 and held it in 8 quarters.
  • JP Morgan Chase's Neuraxis position peaked at $34 in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Neuraxis as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.